US Patent Issued to TriSalus Life Sciences on July 14 for "Modulation of vascular adaptation within a tumor to increase therapy uptake within the tumor" (Colorado, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,562, issued on July 14, was assigned to TriSalus Life Sciences Inc. (Westminster, Colo.).

"Modulation of vascular adaptation within a tumor to increase therapy uptake within the tumor" was invented by Scott Davie (Boulder, Colo.), Trevor McCaw (Corte Madera, Calif.), Michael Brick Markham (Boulder, Colo.) and David Benjamin Jaroch (Arvada, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method is provided to modulated vascular adaptation within a tumor so that therapy uptake is increased. The method includes providing a pressure directed therapy system having an infusion lumen, an occluder, a pressure sensor to sense pressure distal of the oc...